Keywords: Ukraine, Market, Economy, Regulatory oversight, VAT on drugs, BMI
Ukrainian pharma market recovering, but economy remains fragile and regulatory oversight is dysfunctional, says BMI
Article | 07 July 2010
The pharmaceutical market the Ukraine is moving toward strong recovery in 2010, with Business Monitor International forecasting a 21.5% US dollar rebound ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
